Pharmacyclics Enters Into Agreement With Roche To Evaluate IMBRUVICA And GAZYVA In Lymphoma And Leukemia
October 16, 2014 at 14:47 PM EDT
Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has entered into a master clinical drug supply agreement with Roche (SIX: ...